Sprucegrove Investment Management LTD Gilead Sciences, Inc. Transaction History

Sprucegrove Investment Management LTD

$1.47 Billion
Q3 2024

A detailed history of Sprucegrove Investment Management LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sprucegrove Investment Management LTD holds 268,966 shares of GILD stock, worth $24.9 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares

268,966

Previous 270,266 0.48%

Holding current value

$24.9 Million

Previous $18.5 Million 21.58%

% of portfolio

1.53%

Previous 1.21%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$66.59 - $83.99 $86,567 - $109,187	-1,300 Reduced 0.48%	268,966 $22.5 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $2.44 Million - $2.82 Million	38,700 Added 16.71%	270,266 $18.5 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $10.3 Million - $12.5 Million	143,600 Added 163.24%	231,566 $17 Million
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $131,886 - $149,562	1,800 Added 2.09%	87,966 $7.13 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $125,550 - $136,977	-1,698 Reduced 1.93%	86,166 $6.46 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $892,053 - $1.02 Million	-11,736 Reduced 11.78%	87,864 $6.77 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $100,503 - $114,504	-1,300 Reduced 1.29%	99,600 $8.26 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $1.53 Million - $2.2 Million	-24,600 Reduced 19.6%	100,900 $8.66 Million
Q3 2022 Nov 09, 2022	SELL	$59.54 - $68.01 $720,434 - $822,921	-12,100 Reduced 8.79%	125,500 $7.74 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $8.33 Million - $9.39 Million	-144,400 Reduced 51.21%	137,600 $8.51 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.97 Million - $2.47 Million	34,000 Added 13.71%	282,000 $16.8 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $1.75 Million - $1.98 Million	-26,900 Reduced 9.79%	248,000 $18 Million
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $189,532 - $204,484	-2,800 Reduced 1.01%	274,900 $19.2 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $19,041 - $20,805	-300 Reduced 0.11%	277,700 $19.1 Million
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $1.47 Million - $1.68 Million	-24,500 Reduced 8.1%	278,000 $18 Million
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $9.19 Million - $10.5 Million	162,300 Added 115.76%	302,500 $17.6 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $8.71 Million - $10.9 Million	140,200 New	140,200 $8.86 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sprucegrove Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sprucegrove Investment Management LTD with notifications on news.

Account

Sprucegrove Investment Management LTD Gilead Sciences, Inc. Transaction History